"We urge you to reject this application in toto, keeping in mind the present and future interest of our nation," the 'Coalition for a GM-Free India' said in the letter.
"There is no scientific, ethical and socio-economic justification for this mustard. From all available information, it is clear that this GM mustard is neither safe, nor beneficial nor needed," the letter said.
India's GM crop regulator had recently recommended the commercial use of genetically-modified mustard in a submission to the environment ministry. It is now upto the environment minister to give his approval.
The Coalition asked the minister to take a "re-look" at the BJP's manifesto commitments and stick to the promises made in it.
"We ask you to get state government views and independent experts' analyses of full biosafety data before you take a final decision," it said.
Noting that it had made a presentation to the Genetic Engineering Appraisal Committee (GEAC), the Coalition said that despite providing valuable scientific evidence and arguments to the regulators, its queries were "unanswered" to this day.
The Coalition had now sought time from the minister to make a presentation "to bring you the truth of GM mustard".
"We are convinced that the proponents, crop developers and the regulators will not bring such material to you nor share with you how fraudulent the testing, appraisal and clearance processes were," they said.
Centre for Genetic Manipulation of Crop Plants (CGMCP), Delhi University South Campus, had submitted an application to the GEAC for the environmental release of GM mustard (brassica juncea) hybrid DMH-11.
The Coalition said they had also interacted with the late Anil Madhav Dave on this matter and the former minister was of the view that India needs a cohesive policy on the matter and that there is no need for this controversy to erupt crop by crop.
Referring to reports that Dave had hinted at holding consultations on the matter, the Coalition although welcoming it, also said that consultative processes are meaningful only if data is shared in the public domain first and responses to various valid questions raised so far are answered with scientific evidence.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
